bioRxivCell BiologyPreprint
Clonal hematopoiesis-associated DNMT3A mutations derepress bivalent Polycomb target genes and enhance macrophage migration
Yuri LeeiD, Philip K. FarahatiD, Jennifer NguyeniD, Yoshiko TakahashiiD, Jung-Yeon LimiD, Xin HuangiD, Camille BrzechffaiD, Marie E. S. Wheeler, Hye-Ju YangiD, Jihye LeeiD, Zachary S. Pope, Daniella Lu, Akshata N. Rudrapatna, Alec P. PankowiD, Xiaoting Chen, Hongseok Yun, Matthew T. WeirauchiD, Ivan MarazziiD, Brad R. RosenbergiD, Emily R. MiraldiiD, Eirini P. PapapetrouiD, S. Armando VillaltaiD, Angela G. FleischmaniD, Minji ByuniD
Abstract
Somatic mutations in the de novo DNA methyltransferase DNMT3A are frequent in clonal hematopoiesis, but how they alter the function of differentiated myeloid cells remains unclear. Here, we used isogenic human embryonic stem cell-derived macrophage models to define the consequences of DNMT3A dysfunction during myeloid differentiation. DNMT3A-mutant macrophages selectively upregulated bivalent Polycomb target genes, accompanied by DNA hypomethylation, reduced H3K27me3 and increased promoter accessibility. Despite broad epigenetic changes across bivalent promoters, transcriptional derepression occurred at a subset of loci characterized by lower baseline DNA methylation and higher H3K27me3, identifying pre-existing chromatin state as a determinant of transcriptional response. This Polycomb-associated program was conserved in murine macrophages and enriched for genes involved in cell migration and wound repair. DNMT3A-mutant macrophages exhibited enhanced migration and preferential early recruitment to injured tissue. These findings link clonal hematopoiesis-associated epigenetic alterations to selective transcriptional reprogramming and altered function of differentiated myeloid cells.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation
- Mesenchymal Stromal Cell Senescence Induced by Dnmt3a-Mutant Hematopoietic Cells is a Targetable Mechanism Driving Clonal Hematopoiesis and Initiation of Hematologic Malignancy
J. J. Mistry, K. A. Young, … J. J. Trowbridge·bioRxiv·Mar 28, 2024
- Clonal hematopoiesis driven by Dnmt3a mutations promotes metabolic disease development
Bowen Yan, Qingchen Yuan, … Olga A. Guryanova·bioRxiv·May 2, 2025
- Variants of DNMT3A cause transcript-specific DNA methylation patterns and affect hematopoietic differentiation
Tanja Božić, Joana Frobel, … Wolfgang Wagner·bioRxiv·May 9, 2018
- DNMT3A-R882 mutations intrinsically drive dysfunctional neutropoiesis from human haematopoietic stem cells
Giovanna Mantica, Aditi Vedi, … Elisa Laurenti·bioRxiv·Oct 8, 2025
- Delayed Trp53 activation protects Dnmt3a-mutant hematopoietic stem cells from inflammatory attrition.
Ludovica Marando, George Giotopoulos, … Brian J.P. Huntly·bioRxiv·Jan 27, 2025